- Q1 2024 Regenxbio Inc Earnings Call TranscriptMay 08, 2024€15.7 (+0.64%)Earnings
- Regenxbio Inc To Discuss Interim Clinical Data TranscriptMar 05, 2024
- Q4 2023 Regenxbio Inc Earnings Call TranscriptFeb 27, 2024€16.8 (+5.00%)Earnings
- Regenxbio Inc Interim Data Update TranscriptJan 16, 2024
- Regenxbio Inc at Stifel Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Regenxbio Inc Earnings Call TranscriptNov 08, 2023€15.3 (+4.79%)Earnings
- Regenxbio Inc Interim Data Update TranscriptNov 06, 2023
- Regenxbio Inc at World Muscle Society 2023 Data Update TranscriptOct 03, 2023
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Regenxbio Inc Earnings Call TranscriptAug 02, 2023€17.2Earnings
- Regenxbio Inc to Host Virtual Investor Day TranscriptJul 11, 2023
- Regenxbio Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Regenxbio Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Regenxbio Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Regenxbio Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Regenxbio Inc Earnings Call TranscriptMay 03, 2023€17.7 (-2.75%)Earnings
- Regenxbio Inc at Chardan Genetic Medicines & Cell Therapy Manufacturing Summit (Virtual) TranscriptApr 25, 2023
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Regenxbio Inc Earnings Call TranscriptFeb 28, 2023Earnings
- Regenxbio Inc To Discuss Interim Data Update Call TranscriptFeb 11, 2023
- Regenxbio Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Regenxbio Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 08, 2022
- Regenxbio Inc at Piper Sandler Healthcare Conference TranscriptDec 01, 2022
- Q3 2022 Regenxbio Inc Earnings Call TranscriptNov 03, 2022€24.6 (-1.60%)Earnings
- Regenxbio Inc To Discuss RGX-314 For The Treatment Of Wet AMD Call TranscriptOct 03, 2022
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Regenxbio Inc Earnings Call TranscriptAug 03, 2022€31.2 (+4.00%)Earnings
- Regenxbio Inc at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Regenxbio Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Regenxbio Inc Earnings Call TranscriptMay 04, 2022€27Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 Regenxbio Inc Earnings Call TranscriptMar 01, 2022€23.27 (+2.51%)Earnings
- Regenxbio Inc at Barclays Gene Editing & Gene Therapy Summit (Virtual) TranscriptNov 15, 2021
- Q3 2021 Regenxbio Inc Earnings Call TranscriptNov 02, 2021€30.96 (+1.64%)Earnings
- Regenxbio Inc at Chardan Genetic Medicines Conference (Virtual) TranscriptOct 05, 2021
- Regenxbio Inc KOL Conference Call to Discuss RGX-314 Data Presentations TranscriptOct 01, 2021
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Regenxbio Inc Call to Discuss Eye Care Collaboration with Abbvie Inc TranscriptSep 13, 2021
- Q2 2021 Regenxbio Inc Earnings Call TranscriptAug 09, 2021€26.39 (-1.53%)Earnings
- Regenxbio Inc at Bank of America NAPA Healthcare Conference (Virtual) TranscriptJun 16, 2021
- Regenxbio Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Regenxbio Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Regenxbio Inc Earnings Call TranscriptMay 05, 2021€27.43 (-2.11%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Regenxbio Inc Earnings Call TranscriptMar 01, 2021€33.76 (+3.12%)Earnings
- Regenxbio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Regenxbio Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Regenxbio Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Regenxbio Inc Earnings Call TranscriptNov 04, 2020€24.45 (+2.69%)Earnings
- Regenxbio Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Regenxbio Inc Earnings Call TranscriptAug 06, 2020€28.49 (+0.35%)Earnings
- Regenxbio Inc RGX-314 Update Call TranscriptAug 04, 2020
- Q1 2020 Regenxbio Inc Earnings Call TranscriptMay 07, 2020€38.14 (-3.27%)Earnings
- Regenxbio Inc REGENXBIO RGX-314 Phase I/IIa Trial Update TranscriptApr 22, 2020
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Regenxbio Inc Earnings Call TranscriptFeb 26, 2020€43.92 (-5.47%)Earnings
- Q3 2019 Regenxbio Inc Earnings Call TranscriptNov 05, 2019€33.16 (-0.78%)Earnings
- Regenxbio Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Regenxbio Inc, Uniqure NV at Citi Biotech Conference TranscriptSep 04, 2019
- Q2 2019 Regenxbio Inc Earnings Call TranscriptAug 07, 2019€36.17 (+2.12%)Earnings
- Regenxbio Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Regenxbio Inc Earnings Call TranscriptMay 07, 2019€46.06 (+0.83%)Earnings
- Regenxbio Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Regenxbio Inc Earnings Call TranscriptFeb 27, 2019€46.09 (-2.23%)Earnings
- Regenxbio Inc Analyst and Investor Event TranscriptFeb 21, 2019
Regenxbio Inc REGENXBIO RGX-314 Phase I/IIa Trial Update Transcript
Good morning, and welcome to the REGENXBIO conference call to review additional positive long-term interim Phase I/IIa trial update for RGX-314 for the treatment of wet AMD. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the call over to Mr. Patrick Christmas, Senior Vice President and General Counsel for REGENXBIO. You may begin.
Good morning, and thank you for joining us today. With us are Ken Mills, REGENXBIO's President and Chief Executive Officer; Dr. Steve Pakola, our Chief Medical Officer; and several esteemed retinal physicians and key opinion leaders: Dr. Allen Ho, Director of Retina Research at Wills Eye Hospital and Mid-Atlantic Retina; Dr. Robert Avery, Founder of California Retina Consultants and Research Foundation; and Dr. Peter Campochiaro, Director of the Retinal Cell and Molecular Laboratory at Johns Hopkins Wilmer Eye Institute.
Earlier this morning, REGENXBIO provided an update via press
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)